| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | EW71EE171J |
| InChI Key | HXTGXYRHXAGCFP-OAQYLSRUSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H28FNO3 |
| Molecular Weight | 373.47 |
| AlogP | 3.83 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 41.93 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 27.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Serotonin 2a (5-HT2a) receptor antagonist |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sleep Wake Disorders | 3 | D012893 | ClinicalTrials |
| Depressive Disorder | 2 | D003866 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL74355 |
| DrugBank | DB16351 |
| EPA CompTox | DTXSID6047363 |
| FDA SRS | EW71EE171J |
| Guide to Pharmacology | 185 |
| PubChem | 5311271 |
| SureChEMBL | SCHEMBL675164 |
| ZINC | ZINC000000598040 |